20 results
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
agreement with SystImmune. Progressing our ESG and health equity initiatives and maintaining our position with the Billion Dollar Roundtable alongside other … items excluded from non-GAAP EPS.
5 Progressing our ESG Strategy and Health Equity Initiatives INCLUSION & DIVERSITY Executive representation
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
8 Jan 24
Regulation FD Disclosure
10:29am
conditions; anticipated closing for Mirati Therapeutics, Karuna Therapeutics & RayzeBio in 1H 2024 Accelerate growth from late 2020s
Our ESG updates … and looking ahead 37 ESG Materiality Assessment Results 2022 ESG Report Completed a global, double ESG materiality assessment1 and identified the8 ESG
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
Statements" and "Use of Non-GAAP Financial Information."
Environmental, Social & Governance (ESG)
As a leading biopharmaceutical company, Bristol … over serious diseases.
On April 2, 2024, the company published its latest ESG report, which details the company's meaningful progress, its evolved ESG
8-K
EX-99.1
3dsms05p68
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
DEFA14A
yfnpzdl4
10 Apr 23
Additional proxy soliciting materials
5:12pm
8-K
EX-99.1
lqiko7ux7uugcelywj1
29 Apr 22
Bristol Myers Squibb Reports First Quarter Financial Results for 2022
7:42am
8-K
EX-99.1
ifxt6mi0l98 jcpf5
26 Oct 22
Bristol Myers Squibb Reports Third Quarter Financial Results for 2022
7:48am
PX14A6G
26jk11ih0uusz
6 Apr 20
Letter to shareholders
6:02am
8-K
EX-99.1
9q6nqrxfpcz726z4tv
27 Jul 22
Bristol Myers Squibb Reports Second Quarter Financial Results for 2022
7:44am
8-K
EX-99.1
r0ajk1l
27 Apr 23
Bristol Myers Squibb Reports First Quarter Financial Results for 2023
7:45am
8-K
EX-99.1
2lgsg9
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
8-K
EX-99.1
w4fnygwajyx 1i
27 Jul 23
Bristol Myers Squibb Reports Second Quarter Financial Results for 2023
7:50am
DEFA14A
u7qgyy 88e
20 Apr 22
Additional proxy soliciting materials
4:30pm
8-K
EX-99.1
5jclld091t hi7n
4 Feb 22
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2021
7:50am
- Prev
- 1
- Next